In this issue
International publications
Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs

Krawczyk, Noa et al (2022) Harm Reduction Journal, 19. https://doi.org/10.1186/s12954-022-00676-8

read more »
Encouraging a ‘generational shift’ in the UKs relationship with drugs. A commentary on the new UK drug strategy. What can be achieved with drug prevention?

Harry Sumnall (2022) International Journal of Drug Policy, 109, 103841

read more »
Childhood trauma, the brain and the social world. A short guide about the importance of social relationships for mental health.

McCrory, Eamon (2022) London: UK Trauma Council.

read more »
Is a brain-based understanding of addiction predominant? An assessment of addiction researchers' conceptions of addiction and their evaluation of brain-based explanations.

Ochterbeck, Doris and Forberger, Sarah (2022) Drug and Alcohol Review, Early online. doi: 10.1111/dar.13520

read more »
Editorial: Dual disorders (addictive and concomitant psychiatric disorders): mechanisms and treatment.

Vorspan, Florence et al (2022) Frontiers in Psychiatry, 13. doi: 10.3389/fpsyt.2022.975674

read more »
A systematic review of genetic polymorphisms associated with bipolar disorder comorbid to substance abuse

de Marco, Adriano et al (2022) Genes, 13, (8).

read more »
Post-traumatic stress disorder (PTSD) symptoms and alcohol and drug use comorbidity at 25 US level I trauma centers.

Nguyen, Jefferson et al (2022) Trauma Surgery & Acute Care Open, 7. doi: 10.1136/tsaco-2022-000913

read more »
Capacity-building in community-based drug treatment services.

Cole, Michael J (2022) Health and Human Rights, 24, (1), pp. 189-202.

read more »
Editorial: Unraveling vulnerability factors in addiction drug use and potential treatments.

Montesinos, Jorge et al (2022) Frontiers in Neuroscience, 16. doi: 10.3389/fnins.2022.958492

read more »
Monitoring the Future Panel Study annual report: National data on substance use among adults ages 19 to 60, 1976-2021.

Patrick, Megan E et al (2022) Ann Arbor, MI: University of Michigan Institute for Social Research.

read more »
A realist evaluation of residential treatment of adults with substance use disorder: development of an initial programme theory.

De Salis, Henry F et al (2022) Journal of Psychosocial Rehabilitation and Mental Health, https://doi.org/10.1007/s40737-022-00290-8

read more »
Music therapy for people with substance use disorders.

Ghetti, Claire et al (2022) Cochrane Database of Systematic Reviews, (5). Art. no.: CD012576. DOI: 10.1002/14651858.CD012576.pub3

read more »
Public health dimension of the world drug problem.

Report by the Director-General. World Health Organization (2022) Geneva: WHO.

read more »
50th session of the Human Rights Council: drug policy highlights.

(2022) London: Harm Reduction International.

read more »
Special section on compulsory drug treatment and rehabilitation, health, and human rights.

(2022) Health and Human Rights Journal, 24, (1).

read more »
Role of melatonin in the management of substance addiction: a systematic review.

Das, Arani et al (2022) Cureus, 14, (7). doi: 10.7759/cureus.26764

read more »
A systematic review and behaviour change technique analysis of remotely delivered alcohol and/or substance misuse interventions for adults.

Howlett, Neil et al (2022) Drug and Alcohol Dependence, 239. doi: 10.1016/j.drugalcdep.2022.109597

read more »
Strategies for enhancing the implementation of school‐based policies or practices targeting diet, physical activity, obesity, tobacco or alcohol use.

Wolfenden, Luke et al (2022) Cochrane Database of Systematic Reviews, (8), Art. no.: CD011677. DOI: 10.1002/14651858.CD011677.pub3

read more »
A high-sugar diet consumption, metabolism and health impacts with a focus on the development of substance use disorder: a narrative review

Volpicelli, Joseph R and Menzies, Percy (2022) Nutrients, 14, (14). doi: 10.3390/nu14142940

read more »
Addressing adolescent substance use with a public health prevention framework: the case for harm reduction.

Winer, James Michael et al (2022) Annals of Medicine, 54, (1), pp. 2123-2136.

read more »
The challenges, opportunities and strategies of engaging young people who use drugs in harm reduction: insights from young people with lived and living experience.

Stowe, M-J et al (2022) Harm Reduction Journal, 19. doi: 10.1186/s12954-022-00663-z

read more »
Quality of life and its correlated factors among patients with substance use disorders: a systematic review and meta-analysis.

Armoon, Bahram et al (2022) Archives of Public Health, 80, (1), p. 179. https://doi.org/10.1186/s13690-022-00940-0

read more »
Commissioning quality standard: alcohol and drug treatment and recovery guidance.

(2022) London: Office for Health Improvement & Disparities.

read more »
The Scottish drug checking project

CREW 2000, University of Stirling (2022) 

read more »
Association of screening and brief intervention with substance use in Massachusetts middle and high schools.

Levy, Sharon et al (2022) JAMA Network Open, 5, (8).

read more »
What’s contaminating Toronto’s drug supply? insights from samples checked by Toronto’s drug checking service January 1 - December 31, 2021.

(2022) Toronto: Centre on Drug Policy Evaluation.

read more »
Trends in the availability and type of drugs sold on the internet via cryptomarkets, June 2021 - May 2022.

(2022) Sydney: National Drug and Alcohol Research Centre.

read more »
Portholes: exploring the maritime Balkan routes.

Scaturro, Ruggero and Kemp, Walter (2022) Geneva: Global Initiative Against Transnational Organized Crime.

read more »
Substance use and common contributors to morbidity: a genetics perspective.

Sanchez-Roige, et al (2022) EBioMedicine, 83. doi: 10.1016/j.ebiom.2022.104212

read more »
Substance use disorder and suicide-related behaviour around dates of parental death and its anniversaries: a register-based cohort study.

Hiyoshi, Ayako et al (2022) The Lancet Public Health, 7, (8), e683-e693.

read more »
Deaths related to drug poisoning in England and Wales: 2021 registrations.

Breen, Paul and Butt, Asim (2022) London: Office for National Statistics.

read more »
Deaths related to drug poisoning by selected substances, England and Wales. [Dataset]

Office for National Statistics. (2022) 

read more »
Scottish drug deaths taskforce evidence paper.

(2022) Scottish Drug Deaths Taskforce

read more »
National mission on drug deaths: plan 2022-2026.

(2022) Edinburgh: The Scottish Government

read more »
Can the ‘ageing cohort theory’ account for the increase in drug-related deaths?

Lewer, Dan (2022) SSA Blog

read more »
Effect of a peer-led behavioral intervention for emergency department patients at high risk of fatal opioid overdose: a randomized clinical trial.

Beaudoin, Francesca L et al (2022) JAMA Network Open, 5, (8).

read more »
Modeling the population-level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia

Chaillon, Antoine et al (2022) Addiction, 117, (5), pp. 1338-1352

read more »
Premature mortality in people affected by co-occurring homelessness, justice involvement, opioid dependence, and psychosis: a retrospective cohort study using linked administrative data.

Tweed, Emily J et al (2022) The Lancet. Public Health, Early online. https://doi.org/10.1016/s2468-2667(22)00159-1

read more »
Development and validation of machine models using natural language processing to classify substances involved in overdose deaths.

Goodman-Meza, David et al (2022) JAMA Network Open, 5, (8).

read more »
Association of methamphetamine and opioid use with nonfatal overdose in rural communities.

Korthuis, P Todd et al (2022) JAMA Network Open, 5, (8).

read more »
NDARC webinar series presentation. Responding to opioid overdose in the community.

Gilliver, Rosie (2022) National Drug and Alcohol Research Centre

read more »
NDARC webinar series presentation. Characteristics of fatal 'novel' synthetic opioid toxicity in Australia.

Darke, Shane (2022) National Drug and Alcohol Research Centre

read more »
Comparative effectiveness of opioid tapering or abrupt discontinuation vs no dosage change for opioid overdose or suicide for patients receiving stable long-term opioid.

Larochelle, Marc R et al (2022) JAMA Network Open, 5, (8). doi: 10.1001/jamanetworkopen.2022.26523

read more »
Effects of substance use, recovery, and non-drug-related online community participation on the risk of a use episode during remission from opioid use disorder: longitudinal observational study.

Naserianhanzaei, Elahe and Koschate-Reis, Miriam (2022) Journal of medical Internet research, 24, (8). doi: 10.2196/36555

read more »
Characteristics of prescription opioid analgesics in pregnancy and risk of neonatal opioid withdrawal syndrome in newborns.

Esposito, Daina B et al (2022) JAMA Network Open, 5, (8).

read more »
Infographic: opioids notifications to the Early Warning System and seizures.

EMCDDA (2022)

read more »
NDARC webinar series presentation: Feasibility and consumer acceptability of take-home fentanyl test strips.

Sutherland, Rachel (2022) National Drug and Alcohol Research Centre

read more »
Fentanyl purity, potency, & synthesis: real-time testing of opioid drug products in the United States.

Krotulski, Alex J et al (2022) USA: Center for Forensic Science Research and Education.

read more »
People who inject drugs: HIV and viral hepatitis monitoring.

(2022) London: Public Health England

read more »
Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations.

(2022) Geneva: World Health Organization

read more »
Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.

Filippini, Graziella et al (2022) Cochrane Database of Systematic Reviews, (5). Art. no.: CD013444. DOI: 10.1002/14651858.CD013444.pub2

read more »
Characterization of cannabis products purchased for medical use in New York state.

Kritikos, Alexandra F and Pacula, Rosalie Liccardo (2022) JAMA Network Open, 5, (8).

read more »
Frequency of adolescent cannabis smoking and vaping in the United States: Trends, disparities and concurrent substance use, 2017-19.

Keyes, Katherine M et al (2022) Addiction, 117, (8), pp. 2316-2324

read more »
Federal regulations of cannabis for public health in the United States

Liccardo Pacula, et al (2022) Los Angelus: USC Schaeffer

read more »
Estimating the effects of legalizing recreational cannabis on newly incident cannabis use

Montgomery, Barrett Wallace et al (2022) PLoS ONE, 17, (7). doi: 10.1371/journal.pone.0271720

read more »
Associations between Canada's cannabis legalization and emergency department presentations for transient cannabis-induced psychosis and schizophrenia conditions: Ontario and Alberta, 2015-2019

Callaghan, Russell C et al (2022) Canadian Journal of Psychiatry, 67, (8), pp. 616-625

read more »
Impacts of recreational cannabis legalization on cannabis use: a longitudinal discordant twin study.

Zellers, Stephanie M et al (2022) Addiction, Early online. doi: 10.1111/add.16016

read more »
A cross-sectional assessment of package labels aimed at children of edible and leaf cannabis discarded in New York City.

Blumenberg, Adam (2022) Toxicology Communications, 6, (1), pp. 79-82

read more »
Content analysis of the corporate social responsibility practices of 9 major cannabis companies in Canada and the US.

Wakefield, Tanner et al (2022) JAMA Network Open, 5, (8).

read more »
Increased cannabis intake during the COVID-19 pandemic is associated with worsening of depression symptoms in people with PTSD

Murkar, A et al (2022) BMC Psychiatry, 22. doi: 10.1186/s12888-022-04185-7

read more »
Comparative harms assessments for cannabis, alcohol, and tobacco: risk for psychosis, cognitive impairment, and traffic accident.

Johnstad, Peter Grahl (2022) Drug Science, Policy and Law, 8. https://doi.org/10.1177/20503245221095228

read more »
Effects of prenatal alcohol and delta-9-tetrahydrocannabinol exposure via electronic cigarettes on motor development

Breit, Kristen R et al (2022) Alcoholism, Clinical and Experimental Research, Early online. doi: 10.1111/acer.14892

read more »
Cannabinoid content and label accuracy of hemp-derived topical products available online and at national retail stores.

Spindle, Tory R et al (2022) JAMA Network Open, 5, (7).

read more »
The Drug Science podcast #69. amphetamine, heroin and cocaine with Prof Aldo Badiani

Nutt, David (2022) London: Drug Science.

read more »
NDARC webinar series presentation. Implications of the revival of therapeutic research on psychedelic drugs.

Hall, Wayne (2022) National Drug and Alcohol Research Centre

read more »
Quantifying GABA in addiction: a review of proton magnetic resonance spectroscopy studies.

Shyu, Claire et al (2022) Brain Sciences, 12, (7)

read more »
Spatial and temporal assessment of crack cocaine use in 13 European cities through wastewater-based epidemiology.

Steenbeek, Ruud et al (2022) The Science of the Total Environment, 847. doi: 10.1016/j.scitotenv.2022.157222

read more »
Alcohol-specific deaths in Scotland 2021.

(2022) Edinburgh: National Records of Scotland

read more »
Modelling the impact of changes in alcohol consumption during the COVID-19 pandemic on future alcohol-related harm in England.

Angus, Colin et al (2022) Sheffield: ScHARR, University of Sheffield

read more »
The relationship between alcohol use and dementia in adults aged over 60 years: A combined analysis of prospective, individual-participant data from 15 international studies.

Mewton, Louise et al (2022) Addiction, Early online. https://doi.org/10.1111/add.16035

read more »
Briefing - MUP and drug use.

(2022) Edinburgh: Scottish Health Action on Alcohol Problems.

read more »
Association between changes in alcohol consumption and cancer risk.

Yoo, Jung Eun et al (2022) JAMA Network Open, 5, (8).

read more »
The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019.

GBD 2019 Cancer Risk Factors Collaborators (2022) The Lancet, 400, (10352), pp. 563-591.

read more »
NDARC webinar series presentation. Impacts of trading restrictions on alcohol-related violence in NSW.

Weatherburn, Don (2022) National Drug and Alcohol Research Centre.

read more »
Smartphone-based alcohol interventions: a systematic review on the role of notifications in changing behaviors toward alcohol.

Williamson, Charlotte et all (2022) Substance Abuse, 43, (1), pp. 1231-1244.  

read more »
Effectiveness of varenicline and cytisine for alcohol use reduction among people with HIV and substance use: a randomized clinical trial.

Tindle, Hilary A et al (2022) JAMA Network Open, 5, (8).

read more »
Foetal alcohol spectrum disorder and investigative interviewing: a systematic review highlighting clinical and legal implications and recommendations.

Gilbert, David J et al (2022) Behavioral Sciences & the Law, 40, (1), pp. 170-185. doi: 10.1002/bsl.2552

read more »
Evidence to inform effective alcohol pricing policies in the European Union.

Angus, Colin (2022) medRXiv, doi: https://doi.org/10.1101/2022.07.28.22277988 (Submitted)

read more »
Ketamine plus alcohol: what we know and what we can expect about this.

Kobayashi, Natalia Harumi Correa et al (2022) International Journal of Molecular Sciences, 23, (14).

read more »
Assessing the feasibility of using place-based health information in alcohol licensing: case studies from seven local authorities in England.

Mooney, John D et al (2022) Cities & Health, https://doi.org/10.1080/23748834.2022.2091880

read more »
NDARC webinar series presentation. How can the illicit drug control field inform the tobacco endgame?

Gartner, Coral (2022) National Drug and Alcohol Research Centre.

read more »
Toward an ontology of tobacco, nicotine and vaping products.

Cox, Sharon et al (2022) Addiction, Early online. doi: 10.1111/add.16010

read more »
Longer-term use of electronic cigarettes when provided as a stop smoking aid: systematic review with meta-analyses.

Butler, Ailsa R et al (2022) Preventive Medicine, doi: 10.1016/j.ypmed.2022.107182

read more »
Medium- and longer-term cardiovascular effects of e-cigarettes in adults making a stop-smoking attempt: a randomized controlled trial.

Klonizakis, Markos et al (2022) BMC Medicine, 20, (1), p. 276

read more »
Prospective association between e-cigarette use frequency patterns and cigarette smoking abstinence among adult cigarette smokers in the United States.

Harlow, Alyssa F et al (2022) Addiction, Early online. doi: 10.1111/add.16009

read more »
Longitudinal assessments of neurocognitive performance and brain structure associated with initiation of tobacco use in children, 2016 to 2021.

Dai, Hongying Daisy et al (2022) JAMA Network Open, 5, (8).

read more »
National Health Interview Survey: Percentage of current cigarette smoking and electronic cigarette use for adults aged 18 and over, United States

National Center for Health Statistics. (2022) 

read more »
Review of industry reports on EU priority tobacco additives part A: main outcomes and conclusions.

Havermans, Anne et al (2022) Tobacco Prevention & Cessation, 8.

read more »
Chemicals found in e-cigarettes.

(2022) Canberra: National Health and Medical Research Council

read more »
Editorial: Reduce the speed and ease of online gambling in order to prevent harm.

Newall, Philip W S (2022) Addiction, Early online. doi: 10.1111/add.16028

read more »
Multi-operator self-exclusion as a harm reduction measure in problem gambling: retrospective clinical study on gambling relapse despite self-exclusion.

Håkansson, Anders and Åkesson, Gunny (2022) JMIR Mental Health, 9, (8). doi: 10.2196/37837

read more »
Clinical services for problematic internet usage.

Roberts, Amanda et al (2022) Current Opinion for Behavioral Sciences, 46. https://doi.org/10.1016/j.cobeha.2022.101180

read more »